The UD research community continues to navigate COVID-19, with health and safety the highest priority. In spite of hardships, we’re facing the pandemic with vigilance and resilience.
A disruptor prevents things from proceeding as usual. But that’s not always bad. In research and education, we’re always turning ideas and methods on their ear in the quest to learn something new…
Biopharmaceuticals have emerged recently and are having a revolutionary impact on vexing diseases such as cancer. The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), headquartered at the University of Delaware, is at the forefront of making medicines more accessible to Americans.
Multiple partnerships took wing in the past year to ensure UD’s scholarly efforts have the broadest and most sustained impact. Learn about the collaborations that ensure a UD world-class educational experience while serving as a major force for economic development.
With significant change all around us, Delaware’s leaders—including the University of Delaware—are working to turn adversity into new opportunity.
